Last week, the Potential Gas Committee released a new report that estimates the potential natural gas resources available in the U.S. at 2,384 trillion cubic feet, an eye-popping 26% increase over the group's late 2010 calculation. While reduced natural gas prices have led to such projects as the Clean Energy Fuels (NASDAQ: CLNE ) America's Natural Gas Highway and Berkshire Hathaway's (NYSE: BRK-A ) BNSF Railway pilot program to test liquefied natural gas (LNG) locomotives, the price of the commodity has also put downward pressure on natural gas stocks in general ��Chesapeake Energy (NYSE: CHK ) , for example, is down about 40% over the last two years.
As is the case with most things, the impact on the long-term viability of LNG as a U.S.-based substitute for other energy sources is one of balance. If the right blend of supply and demand can be maintained, natural gas stocks should soar. If supply becomes too plentiful, however, driving down prices too much, companies will have less financial incentive to develop natural gas further. With the explosion of shale-based supply, the impact on natural gas stocks is in its infancy but a critical area for investors to watch.
Top 5 Beverage Companies To Invest In Right Now: Chino Commercial Bancorp (CCBC)
Chino Commercial Bancorp, incorporated on March 2, 2006, is a bank holding company of Chino Commercial Bank, N.A. (the Bank). The Bank provides a wide variety of lending products for both businesses and consumers. The Bank offers an array of personal, consumer and commercial services generally offered by a locally-managed, independently-operated bank. The Bank provides a range of deposit instruments and general banking services, including checking, savings accounts (including money market demand accounts), certificates of deposit for both business and personal accounts; Internet banking services, such as cash management and Bill Pay; telebanking (banking by phone); and courier services. The Bank operates three full-service banking offices.
Lending Activities
Commercial loan products include lines of credit, letters of credit, term loans, equipment loans, commercial real estate loans, construction loans, accounts receivable financing, working capital financing. Financing products for individuals include auto, home equity, overdraft protection lines and, through a third party provider, MasterCard debit cards. Real estate loan products include construction loans, land loans, mini-perm commercial real estate loans, and home mortgages. As of December 31, 2011, the Company had total assets of $109.7 million and net loans of $55.2 million. Its lending activity is concentrated primarily in real estate loans, which constituted 81.3% of the Company�� loan portfolio as of December 31, 2011, and commercial loans, which constituted 17.6%, of the Company�� loan portfolio as of December 31, 2011.
Investment activities
The Company�� investment security portfolio consists of United States government agency securities, mortgaged-backed securities, municipal bonds and corporate bonds. Investment securities held to maturity are carried at cost, which equates to the unpaid principal balances adjusted for amortization of premium and accretion of discounts.
Sources of funds
Deposits are the Company�� primary source of funds. As of December 31, 2011, the Company�� total deposits were $98.1 million. As of December 31, 2011, its deposits included demand deposits, negotiable order of withdrawal (NOW), savings deposits, money market and time deposits.
Advisors' Opinion:- [By Lisa Levin]
Regional - Pacific Banks: This industry rose 1.54% by 10:40 am ET. The top performer in this industry was Chino Commercial Bancorp (OTC: CCBC), which gained 10.2%. Chino Commercial Bancorp's trailing-twelve-month operating margin is 27.57%.
Top Clean Energy Companies To Buy Right Now: Thermo Fisher Scientific Inc(TMO)
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacture, analysis, discovery, and diagnostics. Its Analytical Technologies segment offers analytical instruments to analyze prepared samples, software interpretation tools, laboratory information management systems, and laboratory automation systems; environmental instruments and integrated systems for environmental monitoring, safety, and security applications; and process instruments, integrated systems, and measurement solutions. It also provides diagnostics products used in healthcare laboratories to prepare and analyze patient samples; and biosciences products comprising reagents and consumables used in life science research, drug discovery, and biopharmaceutical production. The company?s Laboratory Products and Services segment offers laboratory equipment, including sample preparation, environment storage and handling equipment, and laboratory workstations; laboratory consumables; research market solutions consisting of chemicals, instruments and apparatus, liquid handling pumps and devices, and capital equipment and consumables; and healthcare market products comprising analytical equipment, diagnostic tools, and reagents and consumables. It also provides workplace and first responder equipment, protective gear, and apparel; and packaging, warehousing, distribution, labeling, pharmaceutical and biospecimen storage, and analytical laboratory services in the area of drug discovery and pharmaceutical clinical trials. The company serves pharmaceutical and biotechnology companies, hospitals and clinical diagnostic labs, universities, research institutions, government agencies, and environmental and industrial process control settings primarily in the United States, Germany, and the United Kingdom. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
Advisors' Opinion:- [By Victor Selva]
As we can see, the firm has a lower ROE than Abbott Laboratories (ABT), Thermo Fisher Scientific Inc. (TMO) and CVS Caremark Corporation (CVS).
Final Comment
- [By David Williamson]
Shares of Life Technologies (NASDAQ: LIFE ) jumped in January, when the company announced it was looking for a potential buyer, and it may now be close to a decision, with solid offers having come in both from Blackstone Group (NYSE: BX ) and Thermo Fisher Scientific (NYSE: TMO ) . What will this biotech decide, and how will it affect investors? In this video, Motley Fool health-care analyst David Williamson gives us a breakdown of the offers on the table, and how investors could be affected depending on the outcome.
- [By Rich Smith]
The�megabillion-dollar buyout�of Life Technologies (NASDAQ: LIFE ) by Thermo Fisher Scientific (NYSE: TMO ) grabbed a lot of headlines earlier this week. Fool contributor Rich Smith, however, has a different story to tell.
- [By Holly LaFon]
Besides Yahoo, Loeb�� top holdings are AIG (AIG), Liberty Global Group Inc. (LBTYA) and Thermo Fisher Scientific Inc. (TMO), up 42%, 19% and 17%, respectively, from his average purchase price.
Top Clean Energy Companies To Buy Right Now: World Fuel Services Corporation (INT)
World Fuel Services Corporation, a fuel logistics company, engages in marketing, selling, and distributing aviation, marine, and land fuel products and related services worldwide. The company operates in three segments: Aviation, Marine, and Land. The Aviation segment offers fuel and related services to commercial airlines, second and third-tier airlines, cargo carriers, regional and low cost carriers, airports, fixed based operators, corporate fleets, fractional operators, private aircraft, military fleets, and to the U.S. and foreign governments. Its aviation related services include fuel management, price risk management, arranging ground handling, and dispatch services; and arranging and providing international trip planning, including flight plans, weather reports, and overflight permits. The Marine segment offers fuel and related services to international container and tanker fleets, commercial cruise lines, yachts, and time-charter operators, as well as to the U.S. and foreign governments. Its marine fuel related services comprise management services for the procurement of fuel, cost control, quality control, and claims management. This segment also provides various services, which consist of fueling of vessels in port and sea, and transportation and delivery of fuel and fuel products. The Land segment offers fuel and related services to petroleum distributors operating in the land transportation market; retail petroleum operators; and industrial, commercial, and government customers, as well as engages in crude oil marketing activities. Its land related services include management services for the procurement of fuel and price risk management. In addition, the company offers transaction management services, which consists of card payment solutions and merchant processing services to customers in the aviation, marine, and land transportation industries. World Fuel Services Corporation was founded in 1984 and is headquartered in Miami, Florida.
Advisors' Opinion:- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, fuel logistics company World Fuel Services (NYSE: INT ) has earned a coveted five-star ranking.
- [By Eric Volkman]
World Fuel Services (NYSE: INT ) is about to pump out its latest distribution to stockholders. The company has declared a quarterly dividend of $0.0375 per share of its stock, to be paid on July 5 to shareholders of record as of June 21.
Top Clean Energy Companies To Buy Right Now: Xing AG (O1BC)
Xing AG, formerly Open Business Club AG, is a Germany-based company engaged in the provision and maintenance of online business communication services. It offers companies enterprise solutions afforded by Web 2.0 and manages the communities for professional networking. It supplies support in establishing new business contacts, expanding and managing the network of contacts and organizing meetings and events. It enables its customers to identify experts in several fields and receive advice on any topic as well as promote themselves in their business environments. It serves a number of networkers worldwide. The product portfolio consists of four categories: openBC platform; openBC Premium Groups; openBC mobile, with mobile phone access; openBC plugin, supporting Lotus Notes and Microsoft Outlook. The solutions are offered in 16 languages and data as well as privacy protection is provided. It co-operates with epublica, a Web-based corporate solution provider and Sevenval AG. Advisors' Opinion:- [By Jonathan Morgan]
RWE AG (RWE), Germany�� second-largest utility, slipped 2.4 percent after RBC Capital Markets cut its recommendation on the stock. Lufthansa followed its European peers higher, recovering some of its Aug. 2 selloff. Xing AG (O1BC), the business social network, jumped the most since October as Deutsche Bank AG (DBK) upgraded its rating on the shares.
Top Clean Energy Companies To Buy Right Now: Mylan Inc (MYL)
Mylan Inc. (Mylan), incorporated in 1970, is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The Company operates a specialty business, which is focused on respiratory, allergy and psychiatric therapies. Through Mylan Laboratories Limited, an Indian subsidiary, it manufactures and supply active pharmaceutical ingredient (API) for its own products and pipeline, as well as for third parties. On December 23, 2011, Mylan completed the acquisition of rights to develop, manufacture and commercialize a generic equivalent to GlaxoSmithKline�� Advair Diskus and Seretide Diskus incorporating Pfizer Inc.��, (Pfizer) dry powder inhaler delivery platform (the Respiratory Delivery Platform). In February 2012, Valeant Pharmaceuticals International, Inc. announced that it has completed the divestiture of 1% clindamycin and 5% benzoyl peroxide gel (IDP-111), a generic version of Benzaclin, and 5% fluorouracil cream, (5-FU), an authorized generic of Efudex, to the Company.
As of December 31, 2011, Mylan marketed a global portfolio of approximately 1,100 different products covering a range of therapeutic categories. It offers a range of dosage forms and delivery systems, including oral solids, topicals, liquids and semi-solids. In addition, it focuses on transdermal patches, high potency formulations, injectables, controlled release and respiratory delivery products. Mylan operates in two segments: Generics and Specialty. Its revenues are derived from the sale of generic and branded generic pharmaceuticals, specialty pharmaceuticals and API. Its generic pharmaceutical business is conducted in the United States and Canada (collectively, North America); Europe, the Middle East, and Africa (collectively, EMEA), and India, Australia, Japan and New Zealand (collectively, Asia Pacific). Its API business is conducted through Mylan Laboratories Limited, which is included within the Asia Pacific region in its Generi! cs segment. Its specialty pharmaceutical business is conducted by Dey Pharma, L.P. (Dey).
Generics Segment
The Company sales in the United States are derived through its wholly owned subsidiary Mylan Pharmaceuticals Inc. (MPI), its primary United States pharmaceutical research, development, manufacturing, marketing and distribution subsidiary, as well as through Mylan Institutional (MI). MPI�� net revenues are derived from the sale of solid oral dosage and transdermal patch products. MI�� net revenues are derived from the sale of its unit dose and injectable product offerings. In the United States, it has product portfolios consisting of approximately 340 products, of which approximately 305 are in capsule or tablet form in an aggregate of approximately 740 dosage strengths. Included in these totals are approximately 40 extended release products in a total of approximately 105 dosage strengths. Also included in it�� the United States product portfolio are four transdermal patch products in a total of 18 dosage strengths, which are developed and manufactured by Mylan Technologies, Inc. (MTI), its wholly owned transdermal technology subsidiary, and marketed and distributed by MPI.
The Company�� North America revenues also include those generated by its wholly owned subsidiary Mylan Pharmaceuticals ULC (MPC), which markets generic pharmaceuticals in Canada. MPC offers a portfolio of approximately 115 products in an aggregate of approximately 250 dosage strengths. Its generic pharmaceutical sales in EMEA are generated by its wholly owned subsidiaries in Europe, through which it has operations in 21 countries.
In France, through the Company�� subsidiary Mylan S.A.S., it markets a retail portfolio of approximately 215 products in an aggregate of approximately 455 dosage strengths. In Italy, it markets through its subsidiary Mylan S.p.A. a portfolio of approximately 150 products in an aggregate of approximately 285 dosage strengths. In Italy, it h! as market! share, based on value and volume, in the company-branded generic retail prescription market. In Spain, it markets through its subsidiary Mylan Pharmaceuticals S.L. a portfolio of approximately 100 products in an aggregate of approximately 220 dosage strengths. In Germany, it markets through its subsidiary Mylan dura a portfolio of approximately 150 products in an aggregate of approximately 330 dosage strengths. In the United Kingdom, it offers a product portfolio of approximately 175 products in an aggregate of approximately 315 dosage strengths. It markets generic pharmaceuticals in Asia Pacific through subsidiaries in Australia, New Zealand, India, Japan and Taiwan.
In Australia, the Company offers a portfolio of approximately 170 products in an aggregate of approximately 440 dosage strengths. Mylan Seiyaku, its wholly owned Japanese subsidiary, offers a portfolio of more than 380 products in an aggregate of approximately 500 dosage strengths. At Mylan Laboratories Limited, its dosage business produces antiretroviral (ARV) products, which are sold outside of India, and other finished dosage form (FDF) products, which are sold to third parties by other Mylan operations globally. In addition, Mylan Laboratories Limited offers a line of FDF products in the ARV market and manufactures non-ARV FDF products that are marketed by Mylan.
Specialty Segment
The Company�� specialty pharmaceutical business is conducted through Dey. Dey�� portfolio consists of branded specialty injectable, nebulized and transdermal products for life-threatening conditions. Dey�� revenues are derived through the sale of the EpiPen Auto-Injector. The EpiPen Auto-Injector, which is used in the treatment of severe allergic reactions, is an epinephrine auto-injector that has been sold in the United States and internationally.
Advisors' Opinion:- [By Jayson Derrick]
According to The Financial Times, Mylan (NYSE: MYL) is considering a stock offer to acquire Swedish based Meda who has a market cap of $4.5 billion. Meda's board convened and issued a statement in which it rejected Mylan's offer and that ��ll continued discussions between Meda and Mylan have been terminated without further actions.��Separately, Mylan has sued Celgene over allegations that Celgene has conducted illegal actions to keep its generic version of its Revlimid and Thalomid drugs off the market. Shares of Mylan gained 1.54 percent, closing at $50.63.
Top Clean Energy Companies To Buy Right Now: Rostelekom OAO (ROSYY)
Rostelecom is a telecommunications services provider and carrier of domestic long distance (DLD) and international long distance (ILD) traffic in the Russian Federation. The Company owns and operates a trunk telecommunications network and carries the bulk of Russia's long-distance and international traffic. The Company renders domestic and international long-distance telecommunications services to end users and provides traffic throughput services to Russian operators, including each of Russia's seven inter-regional companies (IRCs) and alternative operators. In addition, the Company provides telecommunications services to various government entities across Russia and ensures the operation of the ground-based network of television and radio broadcasting channels. In December 2008, through Westelcom, its wholly owned subsidiary, Rostelecom acquired an additional 15.2% interest in CJSC Incom (Incom). Subsequently Incom became a wholly owned subsidiary of the Company. In December 2008, it sold 10.87% interest in CJSC Expo-Telecom.
In February 2008, the Company sold its 10.97% interest in Golden Telecom. In March 2008, the Company sold its 10.30% interest in OJSC AVIANET. In July 2008, Rostelecom acquired a 68.42% interest in OJSC RTComm.RU (RTComm.RU). In September 2008, the Company sold its 15% interest in CJSC Transportation Digital Networks.
The Company has entered into service contracts with the IRCs and other operators of local and intra-regional networks to act as its regional agents. In this capacity, the Company�� agents bill end users, prepare, print and deliver invoices and collect payments from end users and perform customer service functions. Its trunk network, which transmits a Russia's domestic and international long-distance traffic, comprises approximately 150,000 kilometers of digital and analog lines.
The Company�� primary network consists of trunk cables linked to the IRCs networks and to its international exchanges for connections with for! eign operators, as well as a satellite communications network. As of December 31, 2008, the Company�� digital network comprised 49,987 kilometers, including 35,291 kilometers of fiber optic lines (FOLs) and 14,696 kilometers of digital radio-relay lines.
As of December 31, 2008, the Company owned 13 international exchanges, which allow for ILD traffic management, including four in Moscow, two in St. Petersburg (Lyuban) and one each in Rostov-on-Don, Samara, Ekaterinburg, Novosibirsk, Khabarovsk, Kaliningrad and Murmansk. The combined capacity of these switches was 235,500 channels. In addition, the Company had 15 transit and six multi-transit domestic long-distance exchanges interconnected to its telecommunications network for traffic transit that provide access to DLD services to local users. The domestic long-distance exchanges and their connecting digital channels constitute an integrated services digital network (ISDN) with channel switches, to which the networks of IRCs and alternative operators are connected. The trunk exchanges of Moscow and Pavlov Posad route domestic long-distance traffic between switching centers, as well as directly to and from end users.
As of December 31, 2008, the Company�� domestic long-distance trunk network consisted of 675,300 digital and 900 analog channels. Rostelecom provides domestic and international ISDN services through 76 trunk exchanges. The Company has an open network of multimedia communications. Connected to this network are subscriber units in 76 Russian regions and 13 retail outlets.
Rostelecom�� main satellite communications network is operated by 16 nodal land-based stations located in Russia. The Company also operates a second satellite communications network, Reserv, which comprises one central and one periphery land-based station. To enable its operation, it leases channels from OJSC Gazcom, which operates earth satellite vehicle Yamal-200. The Company rents domestic and international fixed satellite chan! nels from! FSUE Space Communications, CJSC SatComLine, CJSC SvyazContactInform, OJSC YamalTelecom and CJSC Zond Holding, which are Russian satellite telecommunications companies that operate satellites in the FSUE Space Communications and Intelsat systems.
The Company competes with TransTelecom, Synterra, FSUE Space Communications, TeliaSonera and Golden Telecom.
Advisors' Opinion:- [By Halia Pavliva]
The Bloomberg Russia-US gauge slipped 0.4 percent to 104.16, paring its advance this month to 7.7 percent. CTC Media Inc. (CTCM), the Nasdaq-listed Russian television company, rallied 2.6 percent to $12.86, the highest level since April 25. The stock has climbed 22 percent this month, making it the best performer on the Bloomberg-Russia gauge. VimpelCom is the second-biggest gainer on the index this month, followed by OAO Rostelecom (ROSYY), which has increased 17 percent after two months of declines.
Top Clean Energy Companies To Buy Right Now: Ensign Group Inc (ENSG)
The Ensign Group, Inc., incorporated in 1999, is a holding company. The Company is a provider of skilled nursing and rehabilitative care services through the operation of 103 facilities, five home health and three hospice operations located in Arizona, California, Colorado, Idaho, Iowa, Nebraska, Nevada, Oregon, Texas, Utah and Washington. Its facilities provide a spectrum of skilled nursing, assisted living, home health and hospice services, including physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients. Its walk-in clinics will offer daily access to healthcare for minor injuries and illnesses, including x-ray and lab services, all from convenient neighborhood locations with no appointments. In March 2014, the Company acquired Horizon Post-Acute and Rehabilitation Center, a 196-bed skilled nursing facility in Glendale, Arizona.
On January 1, 2011, the Company purchased one skilled nursing facility which also offers assisted living and independent living services and one independent living facility. On February 1, 2011, the Company purchased one skilled nursing facility in Utah, which also offers assisted living and independent living services. On March 18, 2011, the Company purchased one assisted living facility in California. On May 15, 2011, the Company purchased a home health and hospice operation in Utah. On June 1, 2011, the Company purchased an assisted living facility in Nevada. On July 18, 2011, the Company acquired nine skilled nursing facilities. On August 1, 2011, the Company acquired a skilled nursing facility in Texas; the Company acquired a skilled nursing facility in Utah, and the Company acquired an independent living facility. On October 1, 2011, the Company acquired a skilled nursing facility in California. On December 1, 2011, the Company acquired a skilled nursing facility in Nevada. On December 30, 2011, the Company acquired an assisted living facility in Ari! zona. In November 2011, the Company acquired Pocatello Care and Rehabilitation Center. On November 22, 2011, the Company acquired Homecare Solutions.
The Company's facilities provide a range of skilled nursing and assisted living services, physical, occupational and speech therapies, and other rehabilitative and healthcare services, for both long-term residents and short-stay rehabilitation patients. As of December 31, 2011, it operated 102 facilities, of which it owned 77 and operated an additional 25 facilities under long-term lease arrangements, and had options to purchase five of those 25 facilities.
The Company's wholly owned subsidiaries, which include the Service Center, provides centralized accounting, payroll, human resources, information technology, legal, risk management and other centralized services to the other operating subsidiaries through contractual relationships with such subsidiaries. The Company also has a wholly owned captive insurance subsidiary (the Captive) that provides some claims-made coverage to the Company's operating subsidiaries for general and professional liability, as well as coverage for some workers' compensation insurance liabilities.
Skilled nursing facility revenue is primarily derived from Medicaid, private pay, managed care and Medicare payors. The Company�� skilled nursing facilities provide Medicaid-covered services to individuals consisting of nursing care, room and board and social services. Rehabilitation therapy revenue is primarily received from private pay and Medicare for services provided at skilled nursing facilities and assisted living facilities. Assisted living facility revenue is primarily derived from private pay residents. In addition, Medicaid or other programs in some states where it operates supplement payments for board and care services provided in assisted living facilities. Hospice revenues are primarily derived from Medicare. It derives substantially all of the revenue from its home health busines! s from Me! dicare and Managed Care sources. Its home health care services generally consist of providing some combination of the services of registered nurses, speech, occupational and physical therapists, medical social workers and certified home health aides.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Ensign Group (Nasdaq: ENSG ) , whose recent revenue and earnings are plotted below.
No comments:
Post a Comment